
Cyclosporine: A strong oral immune-suppressing drug used in short bursts for severe eczema and psoriasis. It works faster than anything else, and blood pressure and kidney function set a hard limit on how long anyone stays on it. Vtama: A once-daily steroid-free cream for plaque psoriasis. It can be used anywhere on the body, including the face and skin folds, and some people stay clear for months after stopping.


Choose for a fast, short burst of control in severe eczema or psoriasis while a longer-term treatment is set up.
Choose for psoriasis or eczema anywhere on the body when you want a once-daily non-steroid with no time limit.
Can you take them together?
Vtama can be used on remaining patches during a cyclosporine course. They do not interact.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.










Inhibits calcineurin: Binds cyclophilin to block a T-cell activation switch. Reduces IL-2 signals: Limits a messenger that helps T cells become active. Calms skin inflammation: Overactive immune responses in skin decrease.
Cyclosporine binds cyclophilin; that complex inhibits calcineurin and T-cell cytokine production. This is a simplified skin-focused explanation of systemic immunosuppression.

Activates AhR: Binds a receptor that helps regulate skin-cell behavior. May rebalance inflammation: Changes in immune signaling may help calm skin. May support the skin barrier: Changes in barrier proteins may help skin function.
Tapinarof is an AhR agonist; the specific therapeutic mechanisms are unknown. Anti-inflammatory and barrier effects are proposed from experimental evidence and are explicitly qualified.
The dose is set by body weight, then adjusted by blood pressure and kidney tests, not by how the skin looks.
Starting dose: About 2.5 mg per kilogram of body weight a day, split into two doses. A severe flare may start around 4 to 5 mg per kilogram a day to get control quickly.
Going up: Raised in small steps every two to four weeks if response is poor, and only if the tests are stable.
Coming down: Once the skin is calm, the dose comes down in stages, to give the next treatment time to work.
Total course: Short by design. Many courses run 8 to 16 weeks. Guidelines advise no more than about a year of continuous treatment, less where possible.
When to Apply: Once a day, at whatever time you will remember. A thin layer over the plaques, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts, which sets it apart from a steroid. Wash your hands afterwards unless your hands are being treated.
How to Start: Once daily from day one, on every plaque you want treated. No ramp-up, and no cap on how much of the body can be covered, so it does not have to be rationed the way a strong steroid does.
If It Irritates: Small red bumps around hair follicles are the most common problem and usually appear in the first few weeks. Most are not infection and often settle without stopping. Stinging or a rash where you applied it is the other pattern, and that one is worth showing your doctor, because a true contact allergy means stopping.
If It’s Not Working: There is one strength, so there is nothing to increase. Give it a full twelve weeks. If plaques are still thick then, the conversation is about adding something else, phototherapy, or moving to a tablet or injection.
Twice a day, about 12 hours apart, at the same times daily. Be consistent about food: always with meals or always without, because switching changes absorption. Swallow capsules whole and leave them in the foil until you take them.
On the liquid, mix it with orange or apple juice in a glass cup, stir and drink it straight away, then rinse the cup with more juice and drink that too. Never use grapefruit juice.
Take it when you remember unless the next dose is close, then skip it. Never take two at once. Tell the prescriber if you miss more than a dose or two, or vomit soon after taking it, because the dose is built around your blood level.
Cyclosporine is monitored more closely than any other skin drug, and that monitoring is why it can be used at all. Blood pressure is measured at every visit, often at home. Kidney function is checked by blood test, twice before starting for a reliable baseline, then every couple of weeks for a month or two, then monthly once the dose is steady. The same draws cover potassium, magnesium, uric acid, liver enzymes, blood counts and cholesterol. Drug blood levels are routine in transplant care, not usually needed at dermatology doses.
Two numbers drive the decisions. A rise in creatinine of about a quarter above your baseline, confirmed on a repeat test, means dropping the dose; about half means stopping. New high blood pressure means lowering the dose or adding a blood pressure medicine, and the choice matters: diltiazem and verapamil push levels up, amlodipine does not.
The interaction list is long. Drugs that raise levels include the azole antifungals, clarithromycin and erythromycin, and some HIV and hepatitis C medicines. Drugs that lower it include rifampin, phenytoin, carbamazepine and St John's wort. It also raises statin levels, so that dose is often reduced, and it interacts with colchicine, digoxin, methotrexate and potassium-sparing water tablets. Bring every prescription, supplement and herbal product to the first visit.
The time limit is the point of all this. Kidney damage builds with continuous use and part of it can be permanent, so guidelines cap continuous treatment at about a year and most dermatology courses are far shorter. Long or repeated use also raises the risk of skin cancer, lymphoma and serious infection, so skin checks continue afterward.
No blood tests are required. There is nothing to check on a lab report, which is one of the practical arguments for a topical over a tablet.
Monitoring is a look at the skin and a conversation, usually at about twelve weeks. Two things get asked about: folliculitis, and whether it is a few bumps or enough to be a problem; and whether the treated skin has become itchy and inflamed in a new way, which points to contact dermatitis rather than psoriasis.
Long term there is no organ risk to track and no skin thinning to watch for, so there is no maximum duration. What is genuinely not known yet is what many years of continuous use looks like, because the drug is recent. A common pattern is to treat until clear, stop, and restart when plaques come back.
Approximate windows, not promises.
First 2 weeksStarting: Itch settles first, often within days, and sleep improves. Tingling or burning in the hands and feet, headache and mild nausea are common early. Blood pressure and kidney tests get checked.
Weeks 2 to 6Working: Redness, weeping and thickness improve clearly. Chronic hives that antihistamines do not control usually settle within a month. Extra hair growth on the face, arms and body and swollen or tender gums start now; both are dose-related and reverse after stopping.
Weeks 8 to 16Plaque psoriasis: Large improvement, often near-clear at the higher end of the dose range. Usually where the course ends and another treatment takes over.
VariableSevere inflammatory ulcers: In pyoderma gangrenosum it stops the ulcer spreading while healing catches up. Response times differ a lot.
ThroughoutThe tests: Blood pressure creeping up and kidney numbers drifting decide whether the dose drops or the drug stops. Neither causes symptoms, which is why the tests are not optional.
First few minutesApplying it: A thin layer once a day on the plaques.
Weeks 1 to 4Starting: Scale and roughness ease before the redness does, often by week four. Folliculitis shows up now if it is going to, usually small tender bumps in hair-bearing areas.
Weeks 4 to 8Working: Plaques flatten and shrink, and color fades from red toward pink or brown.
Weeks 8 to 12Judge it here: Trials measured their main result at twelve weeks, and many people were still improving then. A meaningful minority reached clear or almost clear skin — a realistic target, not a promise.
After stoppingRemission: Unlike a steroid, it does not usually rebound. People who cleared completely often stayed clear for months before restarting.
Sorted by what to do about them.
Generic capsules are cheap next to biologics, part of why the drug is still used. Branded versions cost more without working better.
The visible cost is not the whole cost. Repeated blood tests, blood pressure checks and appointments add up, and none are optional. It is cheaper per month than a biologic but taken for only a few months, so the comparison depends on what comes after.
Insurance generally covers it for severe psoriasis. Eczema coverage varies more in the United States, where that use is off-label.
Brand only, with no generic. It is one of the more expensive topicals for psoriasis and costs far more than a generic steroid or generic calcipotriene.
Coverage varies and prior authorization is common; plans frequently want to see a topical steroid, and often a vitamin D analog, tried first. Manufacturer copay cards exist and the terms change, so check the current one.
Because a tube covers only so much, cost climbs quickly with widespread psoriasis, which is one of the main reasons people end up on a tablet or injection instead.
Faster than anything else for these conditions. Itch improves within days, clearing by four to six weeks.
Most courses run months. Guidelines cap continuous use at about one year, because kidney effects build and some can be permanent.
It raises blood pressure in a meaningful share of people, and that causes no symptoms. Catching it early usually means lowering the dose rather than stopping.
No. Grapefruit, pomelo and Seville oranges block the enzyme that clears it, so levels rise unpredictably. Other citrus is fine.
Both are dose-related. Not dangerous, usually better if the dose comes down, and gone after stopping.
Usually, within weeks to a few months, unless another treatment is running. Planning that before the taper is the point of the short course.
No. It works on a different switch inside the skin cell, the aryl hydrocarbon receptor. That is why there is no time limit and no skin thinning.
Yes — approved for the face and skin folds, one of its main advantages over a steroid.
Most likely folliculitis — small red bumps around hair follicles where you applied it. The most common side effect in the trials, at roughly one in five people, usually mild, and most carried on.
Give it twelve weeks. Some change usually shows by four.
That is a normal way to use it. In the long-term study, many who cleared completely stayed clear for months, then restarted when plaques returned.
Yes, it is also approved for atopic dermatitis, in adults and in children from age two.